TELCOR, a Lincoln, Nebraska company that makes revenue cycle and point-of-care testing software for laboratories and healthcare facilities, acquired Sample Healthcare, an AI workflow startup backed by Y Combinator. TELCOR's own release is dated April 1, 2026, and the announcement was distributed on PR Newswire on April 10. Financial terms were not disclosed.
Sample builds software that reads unstructured documents and carries out multi-step administrative tasks in healthcare billing, including prior authorizations, appeals, payer follow-up and document processing. Its customers include molecular diagnostics companies, oncology groups and laboratories.
Sample will continue to be offered as a standalone platform, so customers can use it on its own or inside TELCOR's system. Its team, led by chief executive and co-founder Ankit Ranjan and co-founder Aash Jain, will take leadership roles at TELCOR, and existing Sample customers will get expanded support, the companies said.
What Sample Healthcare built
Much of the work in a laboratory's revenue cycle still involves staff reading medical records, logging in to insurers' portals and making phone calls to get tests approved and paid. Sample's platform uses AI to interpret that unstructured material and then execute the steps of a workflow, rather than only organising the data for a person to act on.
According to TELCOR, Sample can be deployed within weeks. Most customers start with one targeted workflow and add more once they see a return. The companies said customers have reported higher authorization success rates, faster reimbursement and more throughput without adding staff, though they did not publish figures.
Ranjan said in the announcement: "We founded Sample with a simple belief: administrative headache shouldn't be the bottleneck to accessing care." He added that TELCOR would give the company the reach to put its technology in front of thousands of labs.
“TELCOR executes that work with AI, shifting revenue cycle operations from manual processes to automated execution.”
Why TELCOR is buying
TELCOR was founded in 1995 and describes itself as a leader in laboratory revenue cycle management and point-of-care testing software. Its products cover billing, data integration and operational reporting for laboratories and healthcare facilities. Its release was issued from Lincoln, and the company also lists an office in San Francisco.
The company said it plans to combine its revenue cycle system with Sample's workflow engine. It is first deploying the AI inside its own revenue cycle service operations, using real workflows to test performance before rolling the tools out more widely to its customer base. TELCOR said the work is carried out with human oversight.
Chris Terrano, TELCOR's president of revenue cycle management, said the revenue cycle still depends on people moving between documents, payer portals and phone calls, and that TELCOR now handles that work with AI.
What the companies did not say
Neither company disclosed the price, how the deal was paid for, how much Sample had raised or how many people work there. Apart from Y Combinator, no investors in Sample were named in the announcement, and TELCOR did not say how many customers Sample had at the time of the sale.
TELCOR also did not say whether the Sample brand would be kept over the long term. For now, the companies said, Sample's existing customers will keep using the product and will gain access to TELCOR's support resources.
Automation reaches lab billing
The deal reflects pressure on laboratories and providers from rising administrative costs, staff shortages and tighter reimbursement, which TELCOR cited as the reason for moving from software that manages billing data to software that carries out billing tasks. Prior authorization, in which insurers must approve a test or treatment before it is performed, is one of the tasks Sample automates, along with appeals and payer follow-up.
For TELCOR, buying Sample adds an AI product to an established customer base of laboratories rather than building one in-house. For Sample, the sale offers distribution through a vendor whose software is already used for laboratory billing.
